We are live on
!
Find out more
Creative Planning Portfolio holdings
AUM
$147B
1-Year Est. Return
18.73%
This Fund
S&P 500
This Quarter
Est. Return
+10.9%
1 Year Est. Return
+18.73%
3 Year Est. Return
+48.71%
5 Year Est. Return
+44.71%
10 Year Est. Return
+145.34%
AUM
$27.8B
AUM Growth
+$3.36B
(+14%)
Cap. Flow
+$723M
Cap. Flow
% of AUM
2.6%
Top 10 Holdings %
Top 10 Hldgs %
55.63%
Holding
2,156
New
217
Increased
776
Reduced
764
Closed
175
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core US Aggregate Bond ETF
AGG
|
+$157M |
| 2 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$117M |
| 3 |
State Street SPDR Portfolio S&P 400 Mid Cap ETF
SPMD
|
+$105M |
| 4 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$94M |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$93.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Mid-Cap ETF
VO
|
+$63.3M |
| 2 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$32.3M |
| 3 |
Schwab US REIT ETF
SCHH
|
+$21.3M |
| 4 |
Vanguard Energy ETF
VDE
|
+$18.8M |
| 5 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$12.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 4.74% |
| 2 | Technology | 4.11% |
| 3 | Healthcare | 2.19% |
| 4 | Energy | 2.03% |
| 5 | Consumer Discretionary | 1.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARRY
801
DELISTED
Array Biopharma Inc
ARRY
| $826K | ﹤0.01% |
33,894
+300
| +0.9% | +$6.25K |
|
|
FM
802
DELISTED
iShares Frontier and Select EM ETF
FM
| $826K | ﹤0.01% |
29,030
-123
| -0.4% | -$3.47K |
|
803
Novanta
NOVT
$5.04B
| $822K | ﹤0.01% |
9,700
| – | – |
|
|
CEQP
804
DELISTED
Crestwood Equity Partners LP
CEQP
| $822K | ﹤0.01% |
23,352
+10,069
| +76% | +$326K |
|
805
Sabra Healthcare REIT
SBRA
$5.64B
| $818K | ﹤0.01% |
42,024
+260
| +0.6% | +$4.93K |
|
|
HI
806
DELISTED
Hillenbrand
HI
| $817K | ﹤0.01% |
19,679
+34
| +0.2% | +$1.44K |
|
807
Roku
ROKU
$21.1B
| $816K | ﹤0.01% |
12,655
+240
| +2% | +$12.8K |
|
808
Ameriprise Financial
AMP
$46.8B
| $815K | ﹤0.01% |
6,361
+176
| +3% | +$21.8K |
|
809
State Street SPDR S&P 600 Small Cap Growth ETF
SLYG
$5.02B
| $815K | ﹤0.01% |
13,655
+1,256
| +10% | +$74.2K |
|
810
Scotiabank
BNS
$106B
| $814K | ﹤0.01% |
15,286
+2,062
| +16% | +$113K |
|
811
iShares Expanded Tech-Software Sector ETF
IGV
$13B
| $814K | ﹤0.01% |
19,310
+5,525
| +40% | +$218K |
|
812
Central Garden & Pet Co Class A
CENTA
$2.41B
| $813K | ﹤0.01% |
43,688
| – | – |
|
813
MaxLinear
MXL
$6.49B
| $813K | ﹤0.01% |
31,854
-3,912
| -11% | -$85.5K |
|
|
WMC
814
DELISTED
Western Asset Mortgage Capital Corporation
WMC
| $813K | ﹤0.01% |
7,946
| – | – |
|
815
Harley-Davidson
HOG
$2.68B
| $812K | ﹤0.01% |
22,766
-745
| -3% | -$27.1K |
|
816
M&T Bank
MTB
$36.2B
| $811K | ﹤0.01% |
5,166
-28
| -0.5% | -$4.6K |
|
817
Vanguard FTSE Pacific ETF
VPL
$8.05B
| $807K | ﹤0.01% |
12,248
+600
| +5% | +$38.8K |
|
818
Myers Industries
MYE
$1.18B
| $805K | ﹤0.01% |
47,038
| – | – |
|
819
Labcorp
LH
$24.3B
| $804K | ﹤0.01% |
6,119
-3,059
| -33% | -$377K |
|
820
CMS Energy
CMS
$23.1B
| $803K | ﹤0.01% |
14,455
+1,788
| +14% | +$94.3K |
|
821
iShares MSCI India ETF
INDA
$6.71B
| $803K | ﹤0.01% |
22,777
-21,004
| -48% | -$698K |
|
822
Canadian Imperial Bank of Commerce
CM
$107B
| $799K | ﹤0.01% |
20,204
-104
| -0.5% | -$4.32K |
|
|
HOLX
823
DELISTED
Hologic
HOLX
| $799K | ﹤0.01% |
16,518
-218
| -1% | -$9.83K |
|
824
Fastenal
FAST
$54B
| $795K | ﹤0.01% |
49,456
-3,884
| -7% | -$58.5K |
|
825
Vanguard Materials ETF
VAW
$3B
| $791K | ﹤0.01% |
6,427
+182
| +3% | +$21.8K |
|
Similar funds
Creative Planning's Q1 2019 Portfolio in Review
As of Q1 2019, Creative Planning held 2,156 positions worth $27.8B, up 14% from $24.4B the previous quarter. Its ten largest holdings account for 56% of the portfolio.
Creative Planning's Q1 2019 filing shows 217 new, 776 increased, 764 reduced and 175 closed positions. Its largest new stake was Intercept Pharmaceuticals, Inc.: 33,175 shares worth $3.71M. The largest sale was Vanguard Mid-Cap ETF, an estimated $63.3M.
By sector, the portfolio is most concentrated in Financials at 4.7% of assets, down from 5.2% a quarter earlier, followed by Technology and Healthcare.
- Creative Planning's largest Q1 2019 buy was Intercept Pharmaceuticals, Inc.: 33,175 shares worth $3.71M.
- Creative Planning added most to iShares Core US Aggregate Bond ETF in Q1 2019, an estimated $157M increase.
- Creative Planning's biggest Q1 2019 reduction was Vanguard Mid-Cap ETF, cutting an estimated $63.3M.
- Creative Planning fully exited Kforce in Q1 2019, selling an estimated $3.23M.
- Creative Planning's ten largest holdings make up 56% of its $27.8B portfolio in Q1 2019.
- Creative Planning opened 217 new positions and closed 175 in Q1 2019.
- Creative Planning's portfolio value rose 14% quarter-over-quarter to $27.8B.
Based on Creative Planning's 13F filing for Q1 2019, filed 24 Apr 2019.